Human medicines European public assessment report (EPAR): Celldemic, influenza vaccine (surface antigen, inactivated, prepared in ...
Overview On 22 February 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Celldemic, intended for active immunisation against the …